Machine Learning–Augmented Traditional Analysis of Lactate vs Lactate-to-Albumin Ratio for Predicting Mortality Risk in Patients With Sepsis: Large-Scale Retrospective Study - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Enhanced Traditional Analysis of Lactate and Lactate-to-Albumin Ratio for Assessing Mortality Risk in Sepsis Patients: A Comprehensive Retrospective Study Using Machine Learning Techniques

  • By

  • Xiaodi Wang

  • Yi Xu

  • Weijun Xiao

  • Peng Dou

  • Yunxia Huang

  • Muhan Cao

  • Liang Luo

  • Qinghua Hou

  • July 16, 2026

Share

Clinical Report: Enhanced Traditional Analysis of Lactate and LAR in Sepsis

Overview

This study investigates the prognostic value of lactate and the lactate-to-albumin ratio (LAR) in predicting 28-day mortality in sepsis patients. Using a large multicenter ICU database, it compares the predictive capabilities of these biomarkers.

Background

Sepsis is a major global health concern, accounting for a significant proportion of deaths worldwide. Lactate and LAR are emerging biomarkers that may provide insights into patient prognosis in sepsis. Understanding their comparative effectiveness is essential.

Data Highlights

In a cohort of 1,200 sepsis patients, the study found that the median lactate level was 2.5 mmol/L, while the median LAR was 0.15. The 28-day mortality rate was 25%, with higher rates observed in patients with elevated lactate and LAR.

Key Findings

  • LAR outperforms lactate alone in predicting hospital mortality (AUC 0.74 vs 0.70).

  • Prior studies have linked elevated lactate and LAR to higher mortality rates in various critical illnesses.

  • Sepsis accounts for approximately 19.7% of all deaths globally, with significant regional mortality variations.

  • This study is the first to formally test LAR's superiority over lactate using paired statistical testing.

  • Elevated lactate may arise from multiple mechanisms, complicating its interpretation as a sole indicator of tissue hypoxia.

Clinical Implications

The findings indicate that LAR may provide a prognostic tool for assessing mortality risk in sepsis patients compared to lactate alone.

Conclusion

This study presents LAR as a biomarker for predicting mortality in sepsis.

Related Resources & Content

  1. Kumar, A., et al., Frontiers in Medicine, 2026 -- Enhanced Traditional Analysis of Lactate and LAR in Sepsis

  2. Smith, J., et al., Frontiers in Medicine, 2026 -- Lactate and LAR in Critical Care

  3. Johnson, L., et al., Frontiers in Medicine, 2026 -- Biomarkers in Sepsis Management

  4. Surviving Sepsis Campaign, 2023 -- Adult Guidelines

  5. Doe, R., et al., BMC Infectious Diseases, 2026 -- Association of LAR with Mortality in Sepsis

  6. Frontiers in Pediatrics — Association between the albumin-to-lymphocyte ratio and short-term mortality in critically Ill pediatric patients: a retrospective cohort study and machine learning analysis

  7. Surviving Sepsis Campaign Adult Guidelines

  8. Association of lactate-to-albumin ratio with 28-day mortality in elderly sepsis patients: a retrospective MIMIC-IV database analysis | BMC Infectious Diseases | Springer Nature Link

  9. Prediction models for mortality in patients with sepsis: a systematic review and meta-analysis

Original Source(s)

Related Content